Seelos Therapeutics Inc. buy krebskrebs
Start price
03.01.22
/
50%
€1.52
Target price
03.01.23
€2.00
Performance (%)
-56.74%
End price
04.01.23
€0.66
Summary
This prediction ended on 04.01.23 with a price of €0.66. Massive losses of -56.74% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Seelos Therapeutics Inc. | - | - | - |
iShares Core DAX® | 0.961% | -2.210% | 12.839% |
iShares Nasdaq 100 | 2.626% | -1.918% | 38.498% |
iShares Nikkei 225® | 0.217% | -7.216% | 19.425% |
iShares S&P 500 | 1.540% | -1.858% | 27.801% |
Comments by krebskrebs for this prediction
In the thread Seelos Therapeutics Inc. diskutieren
Buy mit Kursziel 2,0
In the thread Trading Seelos Therapeutics Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten